Talphera (TLPH)

• Market cap: $68.1M
• 1 day: -9.59%
• 5 days: -2.22%
• 1 month: 4.76%
• 3 months: 129.73%
• 6 months: 163.11%
• Year to date: 123.69%
• 1 year: 80.9%
• 5 years: -95.71%
• 10 years: -98.83%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Employees: 13